[22] Through the NIH, she serves as the director of the Nutrition Obesity Research Center (NORC) working group on workforce diversity.

[51] Dr. Stanford was featured as a leading voice at the NY Times Deal Book Summit alongside the CEO of Eli Lilly, Dave Ricks, as they discussed the role of GLP-1 receptor agonist in obesity treatment.

[53] In 2018, Stanford said she was racially profiled when administering medical assistance to a fellow passenger on a Delta Airlines flight.

[59] In 2025, she and over 55 international commissioners, led by Dr. Francesco Rubino, proposed a new definition and diagnostic criteria for obesity.

The specific aim of the Lancet Commission was to establish objective criteria for disease diagnosis, aiding clinical decision-making and prioritization of therapeutic interventions and public health strategies.